These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37566183)

  • 21. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
    Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
    Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics under the COVID-19 storm.
    Pilla Reddy V; El-Khateeb E; Jo H; Giovino N; Lythgoe E; Sharma S; Tang W; Jamei M; Rastomi-Hodjegan A
    Br J Clin Pharmacol; 2023 Jan; 89(1):158-186. PubMed ID: 33226664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms.
    Boger E; Fridén M
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
    Klimke A; Hefner G; Will B; Voss U
    Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary Delivery of Hydroxychloroquine Nanostructured Lipid Carrier as a Potential Treatment of COVID-19.
    Ali AS; Alrashedi MG; Ahmed OAA; Ibrahim IM
    Polymers (Basel); 2022 Jun; 14(13):. PubMed ID: 35808662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
    Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
    Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
    Pothen L; Yildiz H; Samnick MM; Yombi JC
    Clin Rheumatol; 2021 Apr; 40(4):1649-1657. PubMed ID: 33452660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
    Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
    Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update.
    Joshi G; Thakur S; Mayank ; Poduri R
    Food Chem Toxicol; 2021 May; 151():112106. PubMed ID: 33722600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.
    Purwati ; Miatmoko A; Nasronudin ; Hendrianto E; Karsari D; Dinaryanti A; Ertanti N; Ihsan IS; Purnama DS; Asmarawati TP; Marfiani E; Yulistiani ; Rosyid AN; Wulaningrum PA; Setiawan HW; Siswanto I; Tri Puspaningsih NN
    PLoS One; 2021; 16(6):e0252302. PubMed ID: 34143818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
    Morita S; Takahashi T; Yoshida Y; Yokota N
    Ther Drug Monit; 2016 Apr; 38(2):259-67. PubMed ID: 26587870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.
    Romani S; Gérard A; Fresse A; Viard D; Van-Obberghen É; Micallef J; Rocher F; Drici MD;
    Clin Transl Sci; 2021 Jan; 14(1):163-169. PubMed ID: 32964653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
    Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
    Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
    Sands K; Wenzel R; McLean L; Korwek K; Roach J; Miller K; Poland RE; Burgess LH; Jackson E; Perlin JB
    Int J Infect Dis; 2021 Mar; 104():34-40. PubMed ID: 33359949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox sensitive nano-capsules self-assembled from hyaluronic acid-hydroxychloroquine conjugates for CD44-targeted delivery of hydroxychloroquine to combat breast cancer metastasis in vitro and in vivo.
    He Y; Xu Y; Huang Y; Quang H; Xia X; Zhao H; Xiao Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2022 Feb; 210():112249. PubMed ID: 34864404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis.
    Carmichael SJ; Charles B; Tett SE
    Ther Drug Monit; 2003 Dec; 25(6):671-81. PubMed ID: 14639053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.